Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis . . .

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date01/25/16 → 01/24/18

Funding

  • Vertex Pharmaceuticals Incorporated: $38,716.50